259 related articles for article (PubMed ID: 24337383)
1. GM-CSF modulates autoantibody production and skin blistering in experimental epidermolysis bullosa acquisita.
Samavedam UK; Iwata H; Müller S; Schulze FS; Recke A; Schmidt E; Zillikens D; Ludwig RJ
J Immunol; 2014 Jan; 192(2):559-71. PubMed ID: 24337383
[TBL] [Abstract][Full Text] [Related]
2. Radiosensitive Hematopoietic Cells Determine the Extent of Skin Inflammation in Experimental Epidermolysis Bullosa Acquisita.
Iwata H; Witte M; Samavedam UK; Gupta Y; Shimizu A; Ishiko A; Schröder T; Seeger K; Dahlke M; Rades D; Zillikens D; Ludwig RJ
J Immunol; 2015 Sep; 195(5):1945-54. PubMed ID: 26202985
[TBL] [Abstract][Full Text] [Related]
3. Complement-fixing anti-type VII collagen antibodies are induced in Th1-polarized lymph nodes of epidermolysis bullosa acquisita-susceptible mice.
Hammers CM; Bieber K; Kalies K; Banczyk D; Ellebrecht CT; Ibrahim SM; Zillikens D; Ludwig RJ; Westermann J
J Immunol; 2011 Nov; 187(10):5043-50. PubMed ID: 21967893
[TBL] [Abstract][Full Text] [Related]
4. NADPH oxidase is required for neutrophil-dependent autoantibody-induced tissue damage.
Chiriac MT; Roesler J; Sindrilaru A; Scharffetter-Kochanek K; Zillikens D; Sitaru C
J Pathol; 2007 May; 212(1):56-65. PubMed ID: 17380558
[TBL] [Abstract][Full Text] [Related]
5. T cells mediate autoantibody-induced cutaneous inflammation and blistering in epidermolysis bullosa acquisita.
Bieber K; Witte M; Sun S; Hundt JE; Kalies K; Dräger S; Kasprick A; Twelkmeyer T; Manz RA; König P; Köhl J; Zillikens D; Ludwig RJ
Sci Rep; 2016 Dec; 6():38357. PubMed ID: 27917914
[TBL] [Abstract][Full Text] [Related]
6. Recombinant human IgA1 and IgA2 autoantibodies to type VII collagen induce subepidermal blistering ex vivo.
Recke A; Trog LM; Pas HH; Vorobyev A; Abadpour A; Jonkman MF; van Zandbergen G; Kauderer C; Zillikens D; Vidarsson G; Ludwig RJ
J Immunol; 2014 Aug; 193(4):1600-8. PubMed ID: 25024393
[TBL] [Abstract][Full Text] [Related]
7. The retinoid-related orphan receptor alpha is essential for the end-stage effector phase of experimental epidermolysis bullosa acquisita.
Sadeghi H; Gupta Y; Möller S; Samavedam UK; Behnen M; Kasprick A; Bieber K; Müller S; Kalies K; de Castro Marques A; Recke A; Schmidt E; Zillikens D; Laskay T; Mariani J; Ibrahim SM; Ludwig RJ
J Pathol; 2015 Sep; 237(1):111-22. PubMed ID: 25953430
[TBL] [Abstract][Full Text] [Related]
8. B cells, dendritic cells, and macrophages are required to induce an autoreactive CD4 helper T cell response in experimental epidermolysis bullosa acquisita.
Iwata H; Bieber K; Tiburzy B; Chrobok N; Kalies K; Shimizu A; Leineweber S; Ishiko A; Vorobyev A; Zillikens D; Köhl J; Westermann J; Seeger K; Manz R; Ludwig RJ
J Immunol; 2013 Sep; 191(6):2978-88. PubMed ID: 23960233
[TBL] [Abstract][Full Text] [Related]
9. Passive transfer of autoantibodies from a patient with mutilating epidermolysis bullosa acquisita induces specific alterations in the skin of neonatal mice.
Borradori L; Caldwell JB; Briggaman RA; Burr CE; Gammon WR; James WD; Yancey KB
Arch Dermatol; 1995 May; 131(5):590-5. PubMed ID: 7741548
[TBL] [Abstract][Full Text] [Related]
10. Heat shock protein 90 is required for ex vivo neutrophil-driven autoantibody-induced tissue damage in experimental epidermolysis bullosa acquisita.
Tukaj S; Hellberg L; Ueck C; Hänsel M; Samavedam U; Zillikens D; Ludwig RJ; Laskay T; Kasperkiewicz M
Exp Dermatol; 2015 Jun; 24(6):471-3. PubMed ID: 25739426
[TBL] [Abstract][Full Text] [Related]
11. Caspase-1-independent IL-1 release mediates blister formation in autoantibody-induced tissue injury through modulation of endothelial adhesion molecules.
Sadeghi H; Lockmann A; Hund AC; Samavedam UK; Pipi E; Vafia K; Hauenschild E; Kalies K; Pas HH; Jonkman MF; Iwata H; Recke A; Schön MP; Zillikens D; Schmidt E; Ludwig RJ
J Immunol; 2015 Apr; 194(8):3656-63. PubMed ID: 25795756
[TBL] [Abstract][Full Text] [Related]
12. Autoantibody-induced intestinal inflammation and weight loss in experimental epidermolysis bullosa acquisita.
Ishii N; Recke A; Mihai S; Hirose M; Hashimoto T; Zillikens D; Ludwig RJ
J Pathol; 2011 Jun; 224(2):234-44. PubMed ID: 21381035
[TBL] [Abstract][Full Text] [Related]
13. Fcγ Receptor IIB Controls Skin Inflammation in an Active Model of Epidermolysis Bullosa Acquisita.
Kovacs B; Tillmann J; Freund LC; Nimmerjahn F; Sadik CD; Bieber K; Ludwig RJ; Karsten CM; Köhl J
Front Immunol; 2019; 10():3012. PubMed ID: 31993051
[TBL] [Abstract][Full Text] [Related]
14. Genetic identification and functional validation of FcγRIV as key molecule in autoantibody-induced tissue injury.
Kasperkiewicz M; Nimmerjahn F; Wende S; Hirose M; Iwata H; Jonkman MF; Samavedam U; Gupta Y; Möller S; Rentz E; Hellberg L; Kalies K; Yu X; Schmidt E; Häsler R; Laskay T; Westermann J; Köhl J; Zillikens D; Ludwig RJ
J Pathol; 2012 Sep; 228(1):8-19. PubMed ID: 22430937
[TBL] [Abstract][Full Text] [Related]
15. T cells are required for the production of blister-inducing autoantibodies in experimental epidermolysis bullosa acquisita.
Sitaru AG; Sesarman A; Mihai S; Chiriac MT; Zillikens D; Hultman P; Solbach W; Sitaru C
J Immunol; 2010 Feb; 184(3):1596-603. PubMed ID: 20038644
[TBL] [Abstract][Full Text] [Related]
16. Epidermolysis bullosa acquisita: what's new?
Ishii N; Hamada T; Dainichi T; Karashima T; Nakama T; Yasumoto S; Zillikens D; Hashimoto T
J Dermatol; 2010 Mar; 37(3):220-30. PubMed ID: 20507385
[TBL] [Abstract][Full Text] [Related]
17. Calcitriol Treatment Ameliorates Inflammation and Blistering in Mouse Models of Epidermolysis Bullosa Acquisita.
Tukaj S; Bieber K; Witte M; Ghorbanalipoor S; Schmidt E; Zillikens D; Ludwig RJ; Kasperkiewicz M
J Invest Dermatol; 2018 Feb; 138(2):301-309. PubMed ID: 28942362
[TBL] [Abstract][Full Text] [Related]
18. Induction of experimental epidermolysis bullosa acquisita by immunization with murine collagen VII.
Sesarman A; Sitaru C
Methods Mol Biol; 2013; 961():371-87. PubMed ID: 23325658
[TBL] [Abstract][Full Text] [Related]
19. Granulocyte-derived elastase and gelatinase B are required for dermal-epidermal separation induced by autoantibodies from patients with epidermolysis bullosa acquisita and bullous pemphigoid.
Shimanovich I; Mihai S; Oostingh GJ; Ilenchuk TT; Bröcker EB; Opdenakker G; Zillikens D; Sitaru C
J Pathol; 2004 Dec; 204(5):519-27. PubMed ID: 15538734
[TBL] [Abstract][Full Text] [Related]
20. Model systems duplicating epidermolysis bullosa acquisita: a methodological review.
Ludwig RJ
Autoimmunity; 2012 Feb; 45(1):102-10. PubMed ID: 21923614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]